INTCO MEDICAL(SZ:300677) Xin Lang Cai Jing·2025-09-08 06:37Group 1 - The core point of the article highlights the recent performance of Yingke Medical, which saw a 5.06% increase in stock price, reaching 36.52 CNY per share, with a trading volume of 555 million CNY and a turnover rate of 3.34%, resulting in a total market capitalization of 23.913 billion CNY [1] - Yingke Medical, established on July 20, 2009, and listed on July 21, 2017, operates in three main business segments: personal protection (90.31% of revenue), rehabilitation care (4.81%), and other products (4.89%) [1] Group 2 - From the perspective of fund holdings, Nanhua Fund has a significant position in Yingke Medical through its Nanhua Fengyuan Quantitative Stock Mixed A fund, which held 48,700 shares, accounting for 1.74% of the fund's net value, ranking as the sixth-largest holding [2] - The Nanhua Fengyuan Quantitative Stock Mixed A fund has achieved a year-to-date return of 18.79%, ranking 3988 out of 8248 in its category, and a one-year return of 41.92%, ranking 3329 out of 8051 [2] Group 3 - The fund manager of Nanhua Fengyuan Quantitative Stock Mixed A is Huang Zhigang, who has a tenure of 13 years and 173 days, with a total fund asset size of 516 million CNY and a best return of 184.4% during his tenure [3] - Co-manager Kang Dong has a tenure of 2 years and 11 days, managing assets of 308 million CNY, with a best return of 16.3% during his tenure [3]